Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials
No copyright
Novadip appoints Soumya Chandramouli as Chief Financial Officer
©No copyright
Exeliom Biosciences
Raising market visibility for a biotech company
Novadip shares positive 12-month results from phase 1b/2a trial with NVDX3 in trauma
No copyright
BiocSol secures additional €4.4M to develop its sustainable crop protection solutions
© David Plas
Novadip reports 12-month results from phase 1b/2a trial of NVD003 to treat rare pediatric disease Congenital Pseudarthrosis of the Tibia
© Novadip
BiocSol
Raising market visibility for an agritech company
Accure Therapeutics partner Oculis reached positive phase 2 results for lead neuroprotective therapy
No copyright
Novadip appoints Drew Trivisonno to the board of directors to drive financial and business development
No copyright